About 1 result found for searched term "Cendakimab" (0.078 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24956 | Cendakimab | IL Receptor/Related |
| RPC 4046; ABT 308; CC-93538 | ||
| Cendakimab (RPC4046; ABT 308; CC-93538) is a selective, humanized, recombinant monoclonal antibody against the IL-13 molecule. Cendakimab has a high affinity and potency for both human wild-type and variant IL-13 and blocks binding of IL-13 to both IL-13Rα1 and IL-13Rα2 with IC50s of 352 pM and 631 pM by ELISA, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
